‘Widespread’ Aspirin Use To Prevent CVD By Consumers At Risk Of Harm, NHIS Data Show
Executive Summary
Aspirin use to prevent CVD "widespread" among US adults who should not use it regularly, according to analysis of 2017 National Health Interview Survey. Nearly half of adults 70 and up without self-reported CVD take aspirin even though guidelines recommend against routine use by persons that age and those with increased bleeding risk.
You may also be interested in...
Recommending Aspirin For CVD Prevention: Understanding Patients Superior To Guidelines – Commentary
Researchers from Florida Atlantic University, University of Wisconsin, Harvard and Brigham and Women’s Hospital suggest medical professionals understanding of their patients supersedes guidelines in making determinations about aspirin use as a primary prevention for cardiovascular events.
Regular Aspirin Use To Prevent Cardiovascular Events Not Advisable For Most Patients – ACC/AHA Guidelines
Aspirin should be used very selectively in the primary prevention of artherosclerotic cardiovascular disease, according to new guidelines from the American College of Cardiology and American Heart Association. While certain higher-risk adults may benefit from regular, preventative aspirin use, those over the age of 70, and any at increased risk of bleeding, should explore lifestyle changes, the groups say.
ASPREE Results Support FDA Aspirin Label Guidance On Cardiovascular Disease
Data from ASPREE trial with more than 19,000 subjects show five-year-use of low-dose aspirin did not prolong disability-free survival and is associated with a significantly higher rate of hemorrhage and somewhat higher rate of all-cause mortality. Findings in three reports in NEJM track with US FDA's guidance that OTC aspirin marketers include a statement referring to doctors when aspirin package labels include a heart or other image suggesting a CV indication.